Package 0310-4505-25

Brand: imjudo

Generic: tremelimumab
NDC Package

Package Facts

Identity

Package NDC 0310-4505-25
Digits Only 0310450525
Product NDC 0310-4505
Product ID 0310-4505_390ff583-8e40-4690-ac4c-b4eaef2229d2
Description

1 VIAL in 1 CARTON (0310-4505-25) / 1.25 mL in 1 VIAL

Marketing

Marketing Status
Marketed Since 2022-10-21
Brand imjudo
Generic tremelimumab
Sample Package No

Linked Drug Pages (1)

IMJUDO ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVENOUS"], "spl_id": "390ff583-8e40-4690-ac4c-b4eaef2229d2", "openfda": {"nui": ["N0000182635", "N0000182634", "N0000182157"], "unii": ["QEN1X95CIX"], "rxcui": ["2619317", "2619323", "2619325", "2619326"], "spl_set_id": ["6690679c-be2f-4588-a2e4-89fff74dd6be"], "pharm_class_pe": ["Increased T Lymphocyte Activation [PE]"], "pharm_class_epc": ["CTLA-4-directed Blocking Antibody [EPC]"], "pharm_class_moa": ["CTLA-4-directed Antibody Interactions [MoA]"], "manufacturer_name": ["AstraZeneca Pharmaceuticals LP"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL in 1 CARTON (0310-4505-25)  / 1.25 mL in 1 VIAL", "package_ndc": "0310-4505-25", "marketing_start_date": "20221021"}], "brand_name": "IMJUDO", "product_id": "0310-4505_390ff583-8e40-4690-ac4c-b4eaef2229d2", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["CTLA-4-directed Antibody Interactions [MoA]", "CTLA-4-directed Blocking Antibody [EPC]", "Increased T Lymphocyte Activation [PE]"], "product_ndc": "0310-4505", "generic_name": "tremelimumab", "labeler_name": "AstraZeneca Pharmaceuticals LP", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "IMJUDO", "active_ingredients": [{"name": "TREMELIMUMAB", "strength": "25 mg/1.25mL"}], "application_number": "BLA761289", "marketing_category": "BLA", "marketing_start_date": "20221021", "listing_expiration_date": "20261231"}